Association of Nuclear YB-1 Localization With Lung Resistance-related Protein and Epidermal Growth Factor Receptor Expression in Lung Cancer

被引:39
作者
Hyogotani, Akira [1 ]
Ito, Ken-ichi [1 ]
Yoshida, Kazuo [1 ]
Izumi, Hiroto [2 ]
Kohno, Kimitoshi [2 ]
Amano, Jun [1 ]
机构
[1] Shinshu Univ, Sch Med, Dept Surg 2, Matsumoto, Nagano 3908621, Japan
[2] Univ Occupat & Environm Hlth, Dept Mol Biol, Yahatanishi Ku, Kitakyushu, Fukuoka 807, Japan
基金
日本学术振兴会;
关键词
Epidermal growth factor receptor; Lung cancer; Lung resistance-related protein; prognosis; Y-box binding protein 1; BOX-BINDING-PROTEIN; MAJOR VAULT PROTEIN; MDR1; GENE-EXPRESSION; HUMAN BREAST CANCERS; SHORT-TERM EXPOSURE; Y-BOX; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; P-GLYCOPROTEIN; OVARIAN-CARCINOMA;
D O I
10.1016/j.cllc.2011.11.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nuclear Y-box binding protein 1 (YB-1) expression significantly correlated with positive lung resistance-related protein (LRP) and epidermal growth factor receptor (EGFR) expression. Tumors positive for nuclear YB-1 and LRP had a significantly worse prognosis, and those positive for nuclear YB-1 and EGFR had a significantly worse prognosis as well. Downregulation of YB-1 with small interfering RNA demonstrated an association of these factors in vitro. Thus, YB-1, LRP, and EGFR expression are of prognostic significance in non-small-cell lung cancer. Background: Y-box binding protein 1 (YB-1) is an oncogenic transcription factor that is activated in response to various genotoxic stresses. The purpose of this study was to elucidate whether YB-1 correlates with the expression of lung resistance-related protein (LRP) and epidermal growth factor receptor (EGFR) in primary lung cancer. Patients and Methods: One hundred and five non-small-cell lung cancer (NSCLC) specimens were analyzed by immunohistochemistry. Knockdown of YB-1 messenger RNA by small interfering RNA(siRNA) was tested for the lung cancer cell lines A549 and Calu-3. Results: Nuclear YB-1 expression significantly correlated with positive LRP and EGFR expression (P < .001). Nuclear YB-1 expression and positive LRP and EGFR expression were independent adverse prognostic factors in patients with NSCLC. Furthermore, patients with tumors positive for nuclear YB-1 and LRP had a significantly worse prognosis than those negative for nuclear YB-1 and LRP (P < .001). In addition, patients with tumors positive for nuclear YB-1 and EGFR had a significantly worse prognosis than those negative for nuclear YB-1 and EGFR (P < .001). In in vitro analyses that use the NSCLC cell lines A549 and Calu-3, the downregulation of YB-1 with siRNAs drastically decreased the expression of EGFR. However, downregulation of YB-1 remarkably decreased the expression of LRP in A549 cells; however, a slight decrease in LRP was induced by the downregulation of YB-1 in Calu-3 cells. Conclusion: Our data demonstrate that nuclear YB-1 localization is associated with LRP and EGFR expression in NSCLC, and nuclear YB-1 localization and LRP and EGFR expression are of prognostic significance in NSCLC.
引用
收藏
页码:375 / 384
页数:10
相关论文
共 56 条
[1]   INVOLVEMENT OF A DNA-BINDING PROTEIN, MDR-NF1/YB-1, IN HUMAN MDR1 GENE-EXPRESSION BY ACTINOMYCIN-D [J].
ASAKUNO, K ;
KOHNO, K ;
UCHIUMI, T ;
KUBO, T ;
SATO, S ;
ISONO, M ;
KUWANO, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 199 (03) :1428-1435
[2]   Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression [J].
Bargou, RC ;
Jurchott, K ;
Wagener, C ;
Bergmann, S ;
Metzner, S ;
Bommert, K ;
Mapara, MY ;
Winzer, KJ ;
Dietel, M ;
Dorken, B ;
Royer, HD .
NATURE MEDICINE, 1997, 3 (04) :447-450
[3]  
Berger W, 2000, INT J CANCER, V88, P293, DOI 10.1002/1097-0215(20001015)88:2<293::AID-IJC23>3.0.CO
[4]  
2-S
[5]  
Brabender J, 2001, CLIN CANCER RES, V7, P1850
[6]   CHARACTERIZATION OF THE CDNA-ENCODING A PROTEIN-BINDING TO THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II Y-BOX [J].
DIDIER, DK ;
SCHIFFENBAUER, J ;
WOULFE, SL ;
ZACHEIS, M ;
SCHWARTZ, BD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (19) :7322-7326
[7]  
Dingemans AMC, 1996, ANN ONCOL, V7, P625
[8]   Expression of HER2 and estrogen receptor α depends upon nuclear localization of Y-box binding protein-1 in human breast cancers [J].
Fujii, Teruhiko ;
Kawahara, Akihiko ;
Basaki, Yuji ;
Hattori, Satoshi ;
Nakashima, Kazutaka ;
Nakano, Kenji ;
Shirouzu, Kazuo ;
Kohno, Kimitoshi ;
Yanagawa, Takashi ;
Yamana, Hideaki ;
Nishio, Kazuto ;
Ono, Mayumi ;
Kuwano, Michihiko ;
Kage, Masayoshi .
CANCER RESEARCH, 2008, 68 (05) :1504-1512
[9]   Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel [J].
Fujita, T ;
Ito, KI ;
Izumi, H ;
Kimura, M ;
Sano, M ;
Nakagomi, H ;
Maeno, K ;
Hama, Y ;
Shingu, K ;
Tsuchiya, SI ;
Kohno, K ;
Fujimori, M .
CLINICAL CANCER RESEARCH, 2005, 11 (24) :8837-8844
[10]   Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer [J].
Gessner, C ;
Woischwill, C ;
Schumacher, A ;
Liebers, U ;
Kuhn, H ;
Stiehl, P ;
Jürchott, K ;
Royer, HD ;
Witt, C ;
Wolff, G .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (01) :14-19